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Abstract
Background: In order to maintain both quality and efficiency of health services in a small country
with a scattered population, Norway established a monopoly system for 38 highly specialized
medical services. The geographical distributions of these services, which are provided by one or
two university hospitals only, were analysed.
Methods: The counties of residence for 2 711 patients admitted for the first time in 2001 to these
31 monopolies and 7 duopolies were identified.
Results: The general tendency observed was that with increasing distance from residential home
to monopoly hospitals there was a declining coverage of these health services. The same pattern
was found even with regard to explicit diagnoses or treatments such as organ transplantations
(except renal transplantations). Duopolies seemed to yield a more even geographical distribution
of the services.
Conclusion: Monopolies may serve as a useful means for maintaining quality in highly specialized
medical services, but seem to have an inherent tendency to do this at the expense of geographical
equality.
Background
During the last 50 years a constant movement of decen-
tralization has taken place in Norwegian health care. One
of the driving forces of this movement has been the docu-
mentation of a poorer health status and a poorer health
service in many parts of district Norway. The University of
Tromsø was thus established primarily in order to educate
doctors and bring specialized health service to the region.
Five health regions, each with a University Hospital, have
later emerged as the main providers and coordinators of
highly specialized health care.
During this process increasing concerns have been raised
regarding the ability of many small hospitals to maintain
quality and efficiency for procedures regarded as the most
difficult, costly and critical. Therefore, in 1990, a monop-
oly system was established, defining a number of highly
specialized and costly medical services in which there was
both a duty for county hospitals to refer patients as well as
a duty for the designated university hospitals to admit
patients in these groups.
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By means of control of purchasing of costly equipment as
well as establishing of special laboratory services and per-
sonnel at selected university hospitals, the government
ascertained that treatment of patients with rare or compli-
cated diseases were not split between several hospitals,
when each of which would not reach a sufficient patient
volume to secure adequate quality of treatment. An
important issue was also to secure that national invest-
ments in expensive medical equipment as well as
resources for training of highly qualified personnel were
targeted to meet the needs on a national level, rather than
to the need of individual hospitals to offer patients a com-
plete set of the most modern and expensive equipments
and treatments.
An analysis of the performance of this unique monopoly
system may offer some lesson also for other countries try-
ing to maintain a balance between too much and too little
centralization in relation to quality and cost control. We
hereby report on what we believe is a fundamental
dilemma facing monopoly systems in health care.
The system
In order to advise the health authorities on the structure
and function of these national monopoly services a pro-
fessional advisory board was established. Each service was
followed and evaluated through regular reports regarding
efficiency, quality, geographical distribution and econ-
omy as well as by site visits. During the years new monop-
oly functions have been established while others have
been deregulated and transferred either to duopolies or to
regionalized functions to be provided by all university
hospitals. Each service should also have a national steer-
ing or advisory committee.
By 2001 there were 31 monopoly functions, 24 of which
were located at the two University Hospitals in the capital
of Oslo (The National Hospital, regional Hospital of
Health Region South, and Ullevål University Hospital, the
regional hospital of Health Region East), four were
located in Bergen and three in Trondheim. Seven duopo-
lies were split between the same hospitals. None of the
functions were located in Northern Norway. The monop-
olies included such services as all types of organ transplan-
tation, cochlea implants in children, surgical treatment of
epilepsy, retinoblastoma, advanced prenatal surgical pro-
cedures and treatment of severe burn injuries. The duopo-
lies included surgery for congenital heart disease in
children and neonatal surgery. Monopolies admitted
from 0 to 431 new patients every year, duopolies from 0
to 200 new patients at each hospital (Table 1).
Methods
In 2001 a thorough review of the entire system was per-
formed [1]. The review was designed to answer the ques-
tion if this centralized system, in addition to securing
services of adequate quality, also was equally accessible
for patients throughout the country. The review included
the identification of the counties of residence for each of
the 2 711 patients admitted and treated for the first time
that year. For the present purpose, the total number of
patients admitted in these services in relation to county of
residence, patient volume and residence in strict monop-
olies as well as patient volume and residence for non-
renal transplantations particularly, are presented. Since all
studied patient data were non-identifiable group data, the
study was exempt from the need of ethical approval.
For analysis of distribution of services the patient volume
from the three northernmost counties (population 464
000) are compared with the remaining 16 counties (pop-
ulation 4 058 000). Furthermore, the combined three
northernmost counties and the four counties in the cen-
tral and west part of the country ("District Norway", pop-
ulation 1 208 000) are compared with the remaining 12
southern counties (population 3 314 000).
Statistical analysis
Statistical analysis was performed by calculating odds
ratio (OR) and confidence intervals for the possibility of
being admitted to any of the centralized highly special-
ized services for a resident of the northern counties, as
well as "district Norway" compared to residents of the rest
of the country.
Results
Table 2 gives the odds ratios and confidence intervals for
the possibility of being admitted to any of the centralized
highly specialized services for a resident of the three
northern counties, as well as "district Norway" compared
to residents of the remaining 16 and 12 counties in the
rest of the country, respectively. As indicated, the general
tendency is that people living in the north and in "district
Norway" have a substantially reduced chance of being
admitted to these highly specialized services. When only
the 31 monopoly functions are analyzed the odds ratios
are somewhat smaller than for the all services combined.
For non-renal organ transplantation the chances of having
access to treatment for a resident in the north is about 1/
3 as for residents in the rest of the country. All the differ-
ences are statistically highly significant with p-levels
below 0.001, except for the comparison of the northern
counties versus the rest with regard to organ transplanta-
tions, which has a p-level of 0.007. To illustrate the varia-
tion between different counties, data for organ
transplantation, radiation neurosurgery and advanced
invasive foetal care, are given in Table 3.BMC Health Services Research 2007, 7:20 http://www.biomedcentral.com/1472-6963/7/20
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Figure 1 summarizes the geographical distribution of the
total volume of highly specialized services in all 19 coun-
ties.
Discussions and conclusion
The significance of the results of the present study
depends on a complete and correct patient volume being
reported for the different services. As pointed out earlier,
by government control, only the designated hospital
would in Norway have access to both the necessary tech-
nology and qualified personnel needed to perform the
defined treatment (Table 1). If a patient at a local hospital
was found to be in need of any of these services, the
patient would thus either be remitted to the designated
hospital for treatment, or not given the treatment at all.
Only isolated cases have been referred to hospitals out of
the country, and then usually after being remitted by the
monopoly hospital. It should also be noted that in Nor-
way all institutional health care, including highly special-
ized services, is provided free of charge for all citizens. The
patient volumes analyzed for these strictly defined serv-
ices are therefore as complete as possible and based on all
available national health statistics.
Some of the monopoly or duopoly functions are, how-
ever, not precisely defined, neither medically or techni-
cally. For such, where the centralized care is defined for
the "advanced", "large" or "complicated" stages of dis-
Table 1: Patient volume in 2001 (patients admitted for the first time) for highly specialized medical services centralized to one 
(monopolies) or two (bipolies) university hospitals in Norway.
Services and/or diagnoses allocated to health service 
monopolies or duopolies
Volume hospital 1 Volume hospital 2 Location (city) of service
All organ transplantations# 354 Oslo
Cardiac arrhytmias (surgical treatment) 5 Oslo
Rheuma surgery in children 53 Oslo
Elective surgery in haemophiliacs 37 Oslo
Cochlea implants in children 33 Oslo
Advanced craniofascial surgery 74 Oslo
Hypoplastic left heart syndrome 8 Oslo
Embolization of cerebral A-V malformations 46 Oslo
Phenylketonuria 5 Oslo
Advanced replantation surgery 48 Oslo
Advanced retinal surgery 0 Oslo
Retinoblastoma 3 Oslo
Trans-sexualism 6 Oslo
Large hemangiomas and vascular malformations 153 Oslo
Diagnosis and treatment of severe epilepsia* 431 Oslo
Surgical treatment of epilepsia 50 Oslo
Choriocarcinoma 4 Oslo
Exentration surgery for gynaecologic. cancer 5 Oslo
Perfusion chemotherapy 5 Oslo
Congenital glaucoma 11 Oslo
Oculoplasty 71 Oslo
Advanced burns 70 Bergen
Elective hyperbar treatment 251 Bergen
Treatment with keratoprosthesis 0 Bergen
Radiation (knife) neurosurgery 178 Bergen
Photopheresis 5 Trondheim
Advanced invasive foetal care 71 Trondheim
Complicated neck and spine disorders 8 Trondheim
Neonatal surgery (excluded cardiac) 80 38 Oslo/Trondheim
Sperm bank 107 94 Oslo/Trondheim
Elective open heart surgery in children 200 49 Oslo/Bergen
Cochlea implants in adults 21 6 Oslo/Bergen
Intersex 8 11 Oslo/Bergen
Cleft lip-jaw-palate 113 45 Oslo/Bergen
Brachytherapy 0 4 Oslo/Bergen
#Includes heart, lung, liver, pancreas, renal and allogenic bone marrow transplantations.
*Includes also the services habilitation for severe epilepsia and pre-surgical evaluation for surgical treatment of epilepsia.BMC Health Services Research 2007, 7:20 http://www.biomedcentral.com/1472-6963/7/20
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ease, patient selection for remittance would be dependant
on the medical evaluation and the level of care at the local
hospital. Variations in the incidence of patients being
remitted by the different counties might for such condi-
tions therefore reflect either a real variation in actual
remittance (we will treat them ourselves), or a variation in
the definition of which patients would need these services
(this is not advanced invasive foetal care). Analyses of var-
iations in case-mix and mortality patterns between differ-
ent counties would not be of any help in evaluating this,
since such differences in disease patterns (advanced, large,
complicated) are not reflected in the national statistics of
diagnoses or procedures.
The management system for the centralized, highly spe-
cialized medical services in Norway seems in general to
have fulfilled the defined purposes, namely to obtain a
reasonable quality, efficiency and economy. Although the
documentation of quality may be difficult in small patient
series, there has definitely been no "Bristol cases" [2] in
this patient population.
The data presented indicate, however, that the fulfilling of
the original objects has been achieved at the expense of a
Table 3: Examples of uneven geographical distribution (incidence for treatment) of patients from the different 19 Norwegian counties 
to the monopoly functions of organ transplantation (located at in Oslo, the Univeristy Hospital of Health Region South), radiation 
neurosurgery (located in Bergen, Health Region West) and Advanced invasive foetal care (located in Trondheim, Health Region 
Middle) treated in 2001. Incidence for treatment is given as treated patients pr. 100.000 residents.
Health Region and County of 
residence
Organ transplantation Radiation neurosurgery Advanced invasive foetal care
Health Region East 8.7 2.9 0.7
Østfold 11.5 2.0 0
Hedmark 5.3 2.1 4.8
Oppland 10.4 1.6 1.1
Oslo 6.6 3.3 0
Akershus 10.9 3.6 0
Health Region South 8.9 2.3 0
Buskerud 10.0 2.1 0
Vestfold 11.6 0.9 0
Telemark 9.0 0.6 0
Aust-Agder 5.3 4.9 0
Vest-Agder 5.1 4.5 0
Health Region West 7.6 9.2 1.9
Rogaland 7.4 7.9 4.7
Hordaland 8.5 10.1 0
Sogn og Fjordane 4.7 10.3 0
Health Region Middle 5.2 3.0 4.4
Møre og Romsdal 2.9 2.9 4.5
Sør-Trøndelag 4.9 4.5 4.5
Nord-Trøndelag 10.2 0 3.9
Health Region North 5.8 1.8 3.0
Nordland 6.7 2.5 5.0
Troms 5.3 0.7 0.7
Finnmark 4.1 1.4 1.4
National average 7.9 3,9 1.6
Table 2: Odds ratio and confidence intervals for the possibility 
for patients from the northern counties of Norway (North) as 
well as the northern and central-west counties combined 
("District Norway") to be admitted in one of the 38 centralized 
highly specialized services compared with patients from the rest 
of the country (Rest) in 2001.
OR 95 % CI
Total services (monopolies and duopolies)
North versus Rest 0.77 0.67 – 0.89
"District Norway" versus Rest 0.78 0.71 – 0.86
Monopolies
North versus Rest 0.73 0.62 – 0.86
"District Norway" versus Rest 0.66 0.59 – 0.73
Non Renal Tx
North versus Rest 0.28 0.09 – 0.78
"District Norway" versus Rest 0.33 0.18 – 0.60BMC Health Services Research 2007, 7:20 http://www.biomedcentral.com/1472-6963/7/20
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Variations between Norwegian counties in usage (admitted patients/100 000 residents) of 38 highly specialized and centralized  medical services Figure 1
Variations between Norwegian counties in usage (admitted patients/100 000 residents) of 38 highly specialized and centralized 
medical services. County usage values are given as the percentage of the national average. The monopoly/duopoly services are 
located at the university hospitals in Oslo, Bergen and Trondheim, while the University hospital in Tromsø does not have any 
such clinical functions.BMC Health Services Research 2007, 7:20 http://www.biomedcentral.com/1472-6963/7/20
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loss of equal access for all residents. Despite the fact that
the performance of these services has been monitored,
highly significant differences in access to the services for
patients from different parts of the country has been dis-
closed. This inequality of access is particularly disturbing
since the medical conditions and treatments covered, such
as organ transplantation, are among the most severe and
critical in relation to life or death, and are services defined
as having a high medical and political priority in the Nor-
wegian National Health Service [3]. It seems unlikely that
the findings can be explained by a lower true demand in
the northern and peripheral parts of the country. Most
health statistics point in the opposite directions regarding
all main disease groups, particularly in the northernmost
counties. Thus, the data have probably disclosed another
example of "the inverse care law" [4].
A number of explanations for these problems of distribu-
tion may be found. The monopoly providers may have
difficulties in announcing their services properly to hospi-
tals 2000 km away from the designated centres, and the
referral institutions in the peripheral parts of the country
may not be properly updated regarding treatment possi-
bilities for small patient groups and niche services. Most
importantly, however, it seems that monopoly institu-
tions as such may have an inherent tendency to cause une-
ven geographical distributions. It may be postulated that
monopolies in health care, as in economy, tend to pacify
both those in charge of and those outside the monopoly
institutions. Some degree of competition may be fruitful,
even in medicine.
International debate regarding equal access to health serv-
ices has in most countries focused on equality linked to
race, social factors, gender, education and economy [5-8].
In the Nordic countries and other countries with a scat-
tered population, geographical maldistribution has been
the main focus [9]. Such a focus seems to be substantiated
by the results of the present study. However, the geo-
graphical differences disclosed may to some extent also be
interpreted in terms of race and social factors. The coun-
ties where patients have the lowest access are thus charac-
terized not only by distance, but also by a lower
educational level and a greater ethnic heterogeneity. This
interpretation is also supported by the fact that residents
of the capital of Oslo, the location of the majority of these
monopoly or duopoly services (Table 1), has a lower use
of these specialized services both compared to the
national average and compared to the more affluent, bet-
ter educated and ethnical more homogenous residents in
the surrounding counties (Fig. 1).
The general experience in Norway is nevertheless that
equal access to most health care has developed as a func-
tion of our regionalized health care system, where univer-
sity hospitals were responsible for patient care in five
defined regions, Health Region East (population 1.6 mil-
lion), Helath Region South (population 875.000), Health
Region West (population 926.000), Health Region Mid-
dle Norway (population 637.000), and Health Region
North (population 464.000). In Northern Norway
improvements came gradually from 1972 with the foun-
dation of the University Hospital of North Norway and
medical school in Tromsø. It has been shown that gradu-
ates from this university to a greater extent than graduates
from the southern medical schools continue to work in
the north, particularly if they are otherwise connected to
the region. As a result of this, more medical specialists and
more specialized medicine have gradually also became
locally available to the people in Northern Norway. In this
period unfavourable mortality differences in Northern
Norway for most of the major malignant diseases as well
as procedure rate differences for invasive cardiology and
heart surgery have all been levelled out, and have in some
instances even been reversed. In spite of this favourable
development, however, there is still an excess total mor-
tality and morbidity in Northern Norway.
Thus, while the regionalized system seems to be adequate
for maintaining the balance between quality and equality
for the majority of patients and health services in general,
including the peripheral parts of the country, the highly
specialized monopoly services has not yet reached this
level of development. In a regionalized system quality
may not always be perfect, but the loss in this aspect is for
the patient probably more than retrieved by a gain in
accessibility.
Our advice to the health authorities in Norway is therefore
that many of these highly specialized services, particularly
those with a relatively large patient volume, also could be
regionalized, even if this would increase costs. Those who
are maintained should be observed and evaluated rigor-
ously, not only with regard to quality, but also to their
geographical and social distribution. By the same logic,
namely a presumed link between quality and quantity, it
could also be argued that some services would be even
better off, maybe also in relation to geographical distribu-
tion, if they were exported to or coordinated with similar
services in other (and larger) countries. This has been sug-
gested but not realized, mainly due to formal issues. The
current development of health care within the European
Union may facilitate such a development.
The ideal of equality has been vigorously debated both on
a philosophical and social level [10,11]. In health care it
has often been presupposed that a society with equal
access must pay for this in terms of a reduced efficiency
and quality [12,13]. This may, however, not be so. In the
parts of society with poor access, patients may be foundPublish with BioMed Central    and   every 
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with a high potential for benefiting from the treatment.
The ideal of equality may therefore help us optimizing
health care for the entire population.
In parallel with increasing affluence as well as level of
medical services, it seems that a gradual weakening of the
ideal of equality has occurred [14]. The present data may
serve to indicate that this ideal needs to be maintained.
Even in a Nordic welfare state an even distribution of
health care can not be taken for granted. A public,
national health care system should be able to give the
same quality and level of services to the entire population.
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